Tricks and Tips

Friday, 22 September 2017

Thyroid Cancer Market Outlooks, Trends Analysis and Forecast by 2017

Thyroid Cancer is a cancer that starts in the thyroid gland. Symptoms include lump that can be felt through the skin on neck, difficulty swallowing, pain in neck and throat and swollen lymph nodes in neck. Predisposing factors include female, high levels of radiation and inherited genetic syndromes. Treatment includes surgery and thyroid hormone therapy.


Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Thyroid Cancer Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Thyroid Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.


The Thyroid Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Thyroid Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 3, 33, 28, 1, 11 and 3 respectively. Similarly, the Universities portfolio in Phase I, Preclinical and Discovery stages comprises 1, 3 and 5 molecules, respectively.

Thyroid Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.


Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Thyroid Cancer (Oncology).
  • The pipeline guide reviews pipeline therapeutics for Thyroid Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
Reasons To Buy
  1. Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  2. Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  3. Find and recognize significant and varied types of therapeutics under development for Thyroid Cancer (Oncology).
  4. Classify potential new clients or partners in the target demographic.
  5. Develop tactical initiatives by understanding the focus areas of leading companies.
For More Details Visit @ Hexa Reports

Pyelonephritis Market Growth Analysis by Region to 2017

Pyelonephritis is a specific type of urinary tract infection (UTI) that generally begins in urethra or bladder and travels up into kidneys. Signs and symptoms include fever, abdominal pain, frequent urination, nausea and vomiting, confusion and back pain or flank pain. Predisposing factors include weakened immune system, obstruction in the urinary tract and damage to nerves around the bladder. Treatment includes antibiotics.

Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Pyelonephritis Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Pyelonephritis (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.


The Pyelonephritis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Pyelonephritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II and Phase I stages are 5, 2 and 1 respectively.

Pyelonephritis (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.


Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Pyelonephritis (Infectious Disease).
  • The pipeline guide reviews pipeline therapeutics for Pyelonephritis (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
Reasons To Buy
  1. Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  2. Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  3. Find and recognize significant and varied types of therapeutics under development for Pyelonephritis (Infectious Disease).
  4. Classify potential new clients or partners in the target demographic.
  5. Develop tactical initiatives by understanding the focus areas of leading companies.
For More Details Visit @ Hexa Reports

Satellite Modem Market Restraint and Industry Analysis to 2022

The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022. This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Satellite Modem industry.


Major Companies
  • ORBCOMM INC. (US)
  • ViaSat Inc. (US)
  • Gilat Satellite Networks Ltd. (IL)
  • Novelsat (IL)
  • Comtech EF Data Corporation (US)
  • Newtec Cy N.V. (BE)
  • Datum Systems (US)
  • Teledyne Paradise Datacom (UK)

Key Regions
  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Asia & Pacific
  • China
  • Japan
  • India

Main types of products

Satellite Modem Market, by Channel Type
  • Single Channel Per Carrier (SCPC) Modems
  • Multiple Channel Per Carrier (MCPC) Modems
Satellite Modem Market, by Data Rate
  • High-Speed Data Rate Modems
  • Mid-Range Data Rate Modems
  • Entry-Level Data Rate Modems
Satellite Modem Market, by Key Consumers
  • Energy & Utilities
  • Mining
  • Telecommunication
  • Marine
  • Military & Defense
  • Transportation & Logistics
  • Oil & Gas
For More Details Visit @ Hexa Reports

Planting Equipment Market End User Estimate and Cost Analysis to 2022

The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022. This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Planting Equipment industry.


Major Companies
  • Deere & Company (U.S.)
  • AGCO Corporation (U.S.)
  • Buhler Industries, Inc. (Canada)
  • Kinze Manufacturing, Inc. (U.S.)
  • Case IH Agricultural Equipment, Inc. (U.S.)
  • Bourgault Industries Ltd. (Canada)
  • Seed Hawk Inc. (Canada)
  • SeedMaster Manufacturing Ltd. (Canada)

Key Regions
  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Russia
  • Asia & Pacific
  • China
  • Japan
  • India

Main types of products

Planting Equipment Market, by Equipment Type
  • Air seeders
  • Seed drills
  • Planters
  • Transplant
  • Others
Planting Equipment Market, by Design
  • Mechanical
  • Automatic
Planting Equipment Market, by Key Consumers
  • Cereals & grains
  • Oilseeds & pulses
  • Fruits & vegetables
  • Turf
For More Details Visit @ Hexa Reports

Computer Assisted Coding Market Restraint and Industry Analysis to 2022

The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2016 to 2022. This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Computer Assisted Coding industry.

Major Companies
  • 3M Health Information Systems (U.S.)
  • Optum, Inc. (U.S.)
  • Nuance Communications, Inc. (U.S.)
  • McKesson Corporation (U.S.)
  • Dolbey Systems, Inc. (U.S.)
  • Precyse Solutions, LLC (U.S.)
  • Artificial Medical Intelligence, Inc. (U.S.)
  • Streamline Health Solutions, LLC (U.S.)

Key Regions
  • United States
  • California
  • Texas
  • New York
  • Canada
  • Mexico
  • Europe
  • Germany
  • British
  • France
  • China
  • Japan
  • India

Main types of products

Computer Assisted Coding Market, by Product & Service
  • Computer-assisted coding solutions
  • Computer-assisted coding services
  • Other
Computer Assisted Coding Market, by Mode Of Delivery
  • Web-based
  • Cloud-based
  • On Premises
  • Other
Key Consumers (End User)
  • Computer Assisted Coding Market, by Consumer
  • Automated computer-assisted encoding
  • Management reporting & analytics
  • Clinical code auditing
For More Details Visit @ Hexa Reports